Market Recap — July 14, 2026
Recap of insider activity, SEC filings, and market-moving news for July 14, 2026.
Last generated Sep 17, 2026, 4:58 PM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Celcuity's REVTORPYK Wins FDA Approval in PIK3CA Wild-Type Breast Cancer, Launch Set for Late Q3
FDA Approves Celcuity's Gedatolisib for Advanced Breast Cancer
Lucid Plunges 45% on Report Bankruptcy Is Being Considered
NextCure to Merge with Avere Therapeutics in All-Stock Deal, Secures $320M PIPE, and Restructures Operations
Activist Group Lifts Jewett Cameron Stake to 12.2% as Q3 Loss Deepens
Shareholders Clear the Way for a Distressed Debt Exchange, Approving a 4 Billion Share Authorization and Reverse Split
Goldenwise Capital Raises Phunware Stake to 6.9% and Threatens Proxy Fight with Scathing Open Letter
VCI Global FY2025 20-F: $30.3M Loss, Material Weaknesses, Auditor Change
Pentair Slashes 2026 EPS Guidance to $3.90-$4.10, CFO Resigns Amid Q2 Sales Plunge
Churchill Capital Corp IX to Liquidate: $10.89/Share Redemption, Warrants Worthless
Churchill Capital IX Misses Business Combination Deadline, Faces Liquidation
AAQL 10-K: Going Concern Warning, Material Weaknesses, and a Strategic Pivot Amid Mounting Losses
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Celcuity's REVTORPYK Wins FDA Approval in PIK3CA Wild-Type Breast Cancer, Launch Set for Late Q3
FDA Approves Celcuity's Gedatolisib for Advanced Breast Cancer
Lucid Plunges 45% on Report Bankruptcy Is Being Considered
NextCure to Merge with Avere Therapeutics in All-Stock Deal, Secures $320M PIPE, and Restructures Operations
Shareholders Clear the Way for a Distressed Debt Exchange, Approving a 4 Billion Share Authorization and Reverse Split
Pentair Slashes 2026 EPS Guidance to $3.90-$4.10, CFO Resigns Amid Q2 Sales Plunge
Churchill Capital Corp IX to Liquidate: $10.89/Share Redemption, Warrants Worthless
Churchill Capital IX Misses Business Combination Deadline, Faces Liquidation
RMCF Q1 Loss Widens to $1.2M, Cash Drops to $609K as Going Concern Looms
Pentair CFO Resigns, Q2 Sales Plunge 17% on Pool Inventory Destocking, Full-Year Guidance Slashed
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Baker Brothers Affiliate Files to Sell $26.8M in Celcuity Stock on FDA Approval Day
Baker Brothers Life Sciences Plans $291M Celcuity Share Sale on FDA Approval Day
CEO Oyler Files to Sell $156M in BeOne Medicines Stock, Upsizing Prior Plan
C3.ai Founder and CEO Thomas Siebel Files to Sell $16.1M in Stock, Adding to Recent $10.1M in Sales
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.